老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Akari Therapeutics PLC

0.8191
+0.00670.82%
盤後：0.7811-0.0380-4.64%18:37 EDT
成交量：2.29萬
成交額：1.87萬
市值：2,671.47萬
市盈率：-1.51
高：0.8340
開：0.8201
低：0.8001
收：0.8124
52周最高：3.85
52周最低：0.5714
股本：3,261.47萬
流通股本：562.08萬
量比：0.03
換手率：0.41%
股息：- -
股息率：- -
每股收益(TTM):-0.5428
每股收益(LYR):-1.6570
淨資產收益率：-112.02%
總資產收益率：-28.56%
市淨率：1.04
市盈率(LYR):-0.49

資料載入中...

總覽公司新聞公告
2023/04/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/07

SEC問詢函

CORRESP [Cover] - Correspondence
2022/11/04

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/10/12

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/05/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/30

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/21

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/30

SEC問詢函

CORRESP [Cover] - Correspondence
2020/11/16

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/07/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/07/17

招股説明書

F-1 - Registration statement for certain foreign private issuers
2020/07/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/04/15

SEC問詢函

CORRESP [Cover] - Correspondence
2020/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多